Attending the GLP-1-Based Therapeutics Summit? On May 15th at 2:00 pm EST Pespectum's Dr. Tom Waddell will discuss the use of quantitative MRI across the entire development pipeline and how it helps GLP 1 clinical trial sponsors differentiate their treatments.

We're excited for #ECO24 ! Meet the #Perspectum team to see how our imaging leads the way in identifying and monitoring multi-organ disease in clinical trials. Click the link to make an appointment.

#obesityresearch #advancedimaging

Attending the GLP-1-Based Therapeutics Summit? On May 15, Pespectum's Dr. Tom Waddell will discuss the use of quantitative MRI across the entire development pipeline and how it helps GLP 1 clinical trial sponsors differentiate their treatments.

Don't miss #Perspectum 's experts at the European Congress on Obesity! Learn how our imaging innovations are changing the detection and monitoring of multi-organ disease as part of sponsors' clinical trials on obesity.

#ECO24 #MASH #obesityresearch

Perspectum is sponsoring the GLP-1-Based Therapeutics Summit in Philadelphia. Meet us at Dr. Tom Waddell's presentation on May 15 at 2:00 pm EST showcasing the role of quantitative multi-organ MRI in enriching clinical trials.

linkedin.com/in/tomhwaddell/

Join us at the European Congress on Obesity in May! Discover #Perspectum 's insights on obesity's link to multi-organ disease and how our imaging tech is transforming detection in clinical trials.

perspectum.com/for-profession…

#ECO24 #obesityresearch

Join us at #ISPOR to hear about the budget impact of MRI biomarker cT1, to identify non-responders on the new MASH medication, Rezdiffra

Read more: ispor.org/heor-resources…

#ISPOR 2024 #Rezdiffra #MRI

What is cT1 and why is it important in in identifying #MASH ?

With more than 128 peer reviewed studies, experience in designing and executing 60+ commercial clinical trials, Perspectum’s LiverMultiScan helps identify MASH, track treatment response and predict patient outcomes. Learn more here:

Learn more: perspectum.com/our-products/l…

#ECCO2024 is in full swing and Perspectum's team is onsite meeting with researchers to discuss how our imaging, digital pathology, and endoscopy services support clinical trials. Want to know more, contact us here: perspectum.com/our-company/co…

Congratulations to our friends at CymaBay Therapeutics. Let's keep working together to tackle liver disease! Patients deserve the best we can give them.

We’re happy to be a part of the excellent discussions at #CMR2024 . To learn more about Perspectum’s leadership in multiorgan imaging, be sure to attend our session at 12:00 today. See the information below. If you can’t make the talk, contact us to learn more. #WhyCMR #HeartMRI

Attending #CMR2024 this week? Perspectum’s SaaS multiparametric imaging helps identify disease, track treatment response, predict outcomes and support clinical trials.

Contact us to learn more: perspectum.com/our-company/co…

#WhyCMR #HeartMRI

CME webinar, “Precision Medicine for Assessing Liver Health and Disease - The Liver: The Unsung Hero of Our Health”, hosted by Medscape Education and supported by Perspectum, will take place 1/24, 12:00 – 12:30 pm EST.

Register here to attend: na.eventscloud.com/website/63611/

In 2023 we closed our Series C financing, and delivered our proprietary imaging technology to 30 pharma trials. Want to know more about our imaging offering? Contact us to book a meeting at JP Morgan Healthcare Conference with Perspectum’s CEO, Dr. Rajarshi Banerjee. #JPMHC24

Perspectum’s CEO, Rajarshi Banerjee, will be attending the J.P. Morgan Healthcare Conference, January 8-10. Learn more about how Perspectum’s imaging solutions can help doctors make better decisions and personalize care for patients in a growing number of diseases. #JPMHC24

Can you believe #RSNA23 is almost over? We’re at Booth 4565 until the end if you haven’t had a chance to stop by it. Talk with our experts about how our Quantitative MRI technology is helping with accurate diagnosis, precise disease monitoring, efficient and scalable throughput.

Can you believe #RSNA23 is almost over? We’re at Booth 4565 until the end if you haven’t had a chance to stop by it. Talk with our experts about how our Quantitative MRI technology is helping with accurate diagnosis, precise disease monitoring, efficient and scalable throughput.

Want to know more about the research that helps LiverMultiScan and our other products improve the accuracy of diagnosis and precision of disease monitoring? Meet Perspectum's experts at booth 4565. Find out about our seamless integration with physician workflows. #RSNA23 #SaaS

Stop by booth #4565 at #RSNA2023 to learn how our products use Quantitative MRI and AI to improve the accuracy of disease diagnosis and the precision of disease monitoring. See how our #SaaS products integrate seamlessly with radiologists’ existing workflows.